91 related articles for article (PubMed ID: 12969327)
1. Alterations in leucocyte trafficking in lupus-prone mice: an examination of the MRL/faslpr mouse.
Hickey MJ
Immunol Cell Biol; 2003 Oct; 81(5):390-6. PubMed ID: 12969327
[TBL] [Abstract][Full Text] [Related]
2. MRL/lpr lupus-prone mice show exaggerated ICAM-1-dependent leucocyte adhesion and transendothelial migration in response to TNF-alpha.
Marshall D; Dangerfield JP; Bhatia VK; Larbi KY; Nourshargh S; Haskard DO
Rheumatology (Oxford); 2003 Aug; 42(8):929-34. PubMed ID: 12730527
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice.
Norman MU; James WG; Hickey MJ
J Leukoc Biol; 2008 Jul; 84(1):68-76. PubMed ID: 18426970
[TBL] [Abstract][Full Text] [Related]
4. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice--roles of intercellular adhesion molecule-1 and P-selectin.
James WG; Hutchinson P; Bullard DC; Hickey MJ
Clin Exp Immunol; 2006 May; 144(2):299-308. PubMed ID: 16634804
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice.
James WG; Bullard DC; Hickey MJ
J Immunol; 2003 Jan; 170(1):520-7. PubMed ID: 12496439
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/fas(lpr) (lupus-prone) mice: roles of P- and E-selectin.
Hickey MJ; Bullard DC; Issekutz A; James WG
J Immunol; 2002 May; 168(9):4728-36. PubMed ID: 11971023
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
8. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation.
Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022
[TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus.
Lloyd CM; Gonzalo JA; Salant DJ; Just J; Gutierrez-Ramos JC
J Clin Invest; 1997 Sep; 100(5):963-71. PubMed ID: 9276713
[TBL] [Abstract][Full Text] [Related]
10. Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL/Faslpr mice through ameliorating inflammation via the PKCδ-NLRC4 axis.
Yang F; Yang Y; Zeng W
Biochem Cell Biol; 2021 Jun; 99(3):313-321. PubMed ID: 33064961
[TBL] [Abstract][Full Text] [Related]
11. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
13. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice.
McHale JF; Harari OA; Marshall D; Haskard DO
J Immunol; 1999 Oct; 163(7):3993-4000. PubMed ID: 10491002
[TBL] [Abstract][Full Text] [Related]
15. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
16. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.
Anam K; Amare M; Naik S; Szabo KA; Davis TA
Lupus; 2009 Apr; 18(4):318-31. PubMed ID: 19276300
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
19. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
[TBL] [Abstract][Full Text] [Related]
20. Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE).
Li Y; Eskelund AR; Zhou H; Budac DP; Sánchez C; Gulinello M
Int J Mol Sci; 2015 Jul; 16(7):15150-71. PubMed ID: 26151848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
